The following MESH search terms were used alone or in combination: “renal cell carcinoma,” “kidney cancer,” “genomics,” “transcriptomics,” “therapeutics,” “molecular classification,” “biomarkers,” “precision medicine,” “immune check inhibitors,” “tyrosine-kinase inhibitors,” and “anti-VEGF.” This evidence concerns the gene VEGFA and renal cell carcinoma.